(Q36825493)

English

A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM.

scientific article published on January 1996

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

F Bressolle

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

C Bologna

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

L Edno

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

J C Bernard

4

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

R Gomeni

5

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

J Sany

6

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

B Combe

7

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

285-292

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Methotrexate in rheumatoid arthritis. An update

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Low-dose methotrexate kinetics in arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients.

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam.

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Some suggestions for measuring predictive performance

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Comparison of serum concentrations of methotrexate after various routes of administration

1 reference

https://api.crossref.org/works/10.1007%2FBF00226329

21 January 2018

Low dose MTX and NSAID induced "mild" renal insufficiency and severe neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacology of methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimate of the number and of the temporal sequence of measurements in a kinetic experiment

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental design and efficient parameter estimation in population pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between methotrexate pharmacokinetic parameters, and clinical and biological status in rheumatoid arthritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal effects of low dose methotrexate in rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of low dose methotrexate therapy in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of concomitant aspirin or prednisone on methotrexate synovial fluid concentration

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of action of methotrexate in rheumatoid arthritis: the search continues

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal interaction between methotrexate and naproxen

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate--the relationship between dose and clinical effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Pancytopenia during rheumatoid polyarthritis treated by low doses of methotrexate]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package

1 reference

https://pubmed.ncbi.nlm.nih.gov/8857074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00226329

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36825493&oldid=2199397868"